Developer docs
API playgroundTry for free, no card

Search company profiles

Biokit

Full company profile

uuid0024z1x

Namestring
Biokit
Legal namestring
Werfen
Websiteurl
biokit.com
Company typeenum
Private
Founded yearint
1973
Descriptiontext

Biokit, doing business as Werfen Immunoassay, is a Barcelona-based contract developer and manufacturer of in vitro diagnostics (IVD) biomaterials and immunoassays, founded in 1973 and operating as a Center of Excellence within the Werfen group from its Lliçà d'Amunt facility. The company develops and manufactures custom antigens, antibodies, and immunoassays in bulk format for global IVD industry leaders, supported by an integrated end-to-end assay lifecycle service that spans bespoke reagent development, clinical studies, worldwide regulatory registration, and on-market product support. Beyond OEM biomaterials supply, Biokit markets a branded portfolio of diagnostic products targeted at blood banks and clinical laboratories.

The business model combines three revenue streams: project-based custom biomaterial development and manufacturing contracts with IVD OEMs (professional services), recurring bulk-format immunoassay supply agreements (subscription/recurring), and one-time branded product sales to blood banks and clinical laboratories. Pricing is quote-based and negotiated per project and is not publicly disclosed. Commercial reach is delivered through Werfen's direct sales offices in over 30 countries complemented by distributor networks covering more than 100 territories globally, supported by technical content marketing (technical notes, webinars, catalogs, blog, tradeshows) targeting IVD professionals.

The customer base comprises more than 60 long-term enterprise IVD relationships, with primary focus on diagnostic kit manufacturers requiring custom antibody and antigen production at scale. Biokit is positioned as a specialized outsource partner rather than a finished-assay brand, leveraging proprietary immunoassay know-how, regulatory expertise accumulated over five decades, and bulk manufacturing scale as its principal competitive advantages. No AI/ML capabilities, funding rounds, or independent management disclosures are present in the source data, and the unit operates within the privately held Werfen group.

Short descriptiontext

Biokit (Werfen Immunoassay) is a Barcelona-based contract developer and manufacturer of custom antigens, antibodies, and bulk immunoassays for global IVD industry leaders, offering end-to-end assay lifecycle services from reagent development through regulatory registration and on-market support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, immunoassay development, antibody manufacturing, antigen production, biomaterial manufacturing
Industry3 codes
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAB
Immunoassay Diagnostics (ELISA, chemiluminescence, serology)
SECONDARYHLAAAKAA
Biologic API/Drug Substance Manufacturing Services
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
In Vitro Diagnostics Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Custom Biomaterial Development and Manufacturing
TypeProfessional Services
Description

Bespoke development and manufacturing of custom antibodies and antigens for IVD companies. Revenue is generated through project-based contracts with long-term customer relationships, typically involving development fees and ongoing supply agreements.

werfen.com
2Bulk Assay Supply
TypeSubscription Recurring
Description

Large-scale production and supply of immunoassays in bulk format to global IVD industry players. Revenue generated through recurring bulk product orders.

werfen.com
3Branded Products for Blood Banks & Clinical Laboratories
TypeOne Time License
Description

Sale of branded diagnostic products to blood banks and clinical laboratories.

werfen.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Biokit operates as Werfen Immunoassay, a Center of Excellence for Immunoassay and Biomaterials. The company provides custom development and bulk manufacturing of high-quality antibodies, antigens, and immunoassays for the global in vitro diagnostics (IVD) industry, and also offers branded finished diagnostic products for blood banks and clinical laboratories. Services span end-to-end assay lifecycle management including bespoke reagent design, optimization, large-scale production, clinical studies, worldwide regulatory registration, and on-market product support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • More than 60 long-term customer relationships in the IVD industry
Product overview1 text field

Werfen Immunoassay operates as a Center of Excellence for Immunoassay and Biomaterials, offering a unified portfolio of products and services for the global IVD industry. The core product portfolio consists of biomaterials (antigens and antibodies) and bulk-format immunoassays, complemented by branded products for blood banks and clinical laboratories. These are supported by service offerings including customized immunoassay development and customized biomaterial development, enabling end-to-end assay lifecycle management from bespoke reagent development through large-scale production.

Product and service5 records
1Biomaterials (Antigens and Antibodies)
CategoryCore product
Description

High-quality custom-developed antigens and antibodies specifically designed for immunoassays, serving as foundational biomaterials for IVD industry customers.

2Immunoassays in Bulk Format
CategoryCore product
Description

Bulk assay supply of immunoassays for diagnostic manufacturers, providing large-scale production capabilities to meet diagnostic manufacturing needs.

3Branded Products for Blood Banks and Clinical Laboratories
CategoryBranded product
Description

Finished branded diagnostic products tailored for blood banking and clinical laboratory applications, including blood typing, compatibility testing, and transfusion safety reagents.

4Customized Immunoassay Service
CategoryService
Description

Bespoke development of custom immunoassays tailored to specific diagnostic requirements, including assay design, optimization, and manufacturing for IVD company partners.

5Customized Biomaterial Service
CategoryService
Description

Customized development and manufacturing of antibodies and antigens to meet specific customer requirements for diagnostic applications.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italy-headquartered IVD company focused on immunoassays and molecular diagnostics, with a similar European manufacturing heritage to Biokit. Overlaps directly in custom and bulk immunoassay reagent supply to clinical labs and IVD partners.

TypeBroad incumbent
Description

Operates one of the largest antibody, antigen, and bioreagent catalogs globally, including custom antibody development services. Competes with Biokit for IVD manufacturers sourcing high-quality antibodies and antigens, though Merck's portfolio spans the full life-science research and bioprocessing markets.

TypeBroad incumbent
Description

Broad life-sciences and diagnostics company offering immunoassay reagents, custom antibody development, and IVD solutions across multiple modalities. Competitor in the IVD reagent supply space though not as specialized in IVD raw-material CDMO services as Biokit.

TypeDirect peer
Description

Specialist provider of monoclonal antibodies and antigens specifically for IVD manufacturers, with a similar custom development and bulk-supply model to Biokit. A directly comparable niche competitor serving global IVD reagent demand.

TypeDirect peer
Description

Global provider of custom antibody services, recombinant protein production, and IVD reagent supply with strong Asia-Pacific manufacturing scale. Directly comparable to Biokit in custom antibody/antigen development for IVD and life-science customers.

TypeDirect peer
Description

Provides IVD reagents, antibodies, and biomaterials to diagnostic manufacturers, including custom development services. Comparable to Biokit as a focused supplier of immunoassay components to global IVD companies.

TypeDirect peer
Description

US-based IVD company producing immunoassay reagents, antigens, and antibodies for diagnostic test manufacturers and clinical laboratories. Overlaps with Biokit in both IVD raw material supply and finished diagnostic test products.

TypeDirect peer
Description

Major diagnostics and life-science company with a portfolio of IVD reagents, immunoassay kits, and quality controls that competes for the same clinical lab and IVD manufacturer customers as Biokit. Bio-Rad also offers custom reagent services, making it a close functional peer in immunoassay supply.

TypeDirect peer
Description

China-based IVD raw-material supplier offering custom antibody and antigen development, bulk reagent manufacturing, and end-to-end IVD solutions. Closely comparable business model to Biokit, often positioned as a lower-cost alternative for global IVD manufacturers.

TypeBroad incumbent
Description

Global life-sciences leader with a substantial antibodies and immunoassay reagents catalog serving IVD and research customers. Overlaps with Biokit in bulk antibody/antigen supply, though Thermo Fisher operates across a much broader life-sciences portfolio rather than specializing in custom IVD reagent CDMO services.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biokit

In Vitro Diagnostics Manufacturingbiokit.com

Biokit (Werfen Immunoassay) is a Barcelona-based contract developer and manufacturer of custom antigens, antibodies, and bulk immunoassays for global IVD industry leaders, offering end-to-end assay lifecycle services from reagent development through regulatory registration and on-market support.

What Biokit does

Biokit, doing business as Werfen Immunoassay, is a Barcelona-based contract developer and manufacturer of in vitro diagnostics (IVD) biomaterials and immunoassays, founded in 1973 and operating as a Center of Excellence within the Werfen group from its Lliçà d'Amunt facility. The company develops and manufactures custom antigens, antibodies, and immunoassays in bulk format for global IVD industry leaders, supported by an integrated end-to-end assay lifecycle service that spans bespoke reagent development, clinical studies, worldwide regulatory registration, and on-market product support. Beyond OEM biomaterials supply, Biokit markets a branded portfolio of diagnostic products targeted at blood banks and clinical laboratories.

The business model combines three revenue streams: project-based custom biomaterial development and manufacturing contracts with IVD OEMs (professional services), recurring bulk-format immunoassay supply agreements (subscription/recurring), and one-time branded product sales to blood banks and clinical laboratories. Pricing is quote-based and negotiated per project and is not publicly disclosed. Commercial reach is delivered through Werfen's direct sales offices in over 30 countries complemented by distributor networks covering more than 100 territories globally, supported by technical content marketing (technical notes, webinars, catalogs, blog, tradeshows) targeting IVD professionals.

The customer base comprises more than 60 long-term enterprise IVD relationships, with primary focus on diagnostic kit manufacturers requiring custom antibody and antigen production at scale. Biokit is positioned as a specialized outsource partner rather than a finished-assay brand, leveraging proprietary immunoassay know-how, regulatory expertise accumulated over five decades, and bulk manufacturing scale as its principal competitive advantages. No AI/ML capabilities, funding rounds, or independent management disclosures are present in the source data, and the unit operates within the privately held Werfen group.

Biokit firmographics

Firmographics
Name
Biokit
Legal name
Werfen
Website
https://biokit.com
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
11–50 employees
Short description
Biokit (Werfen Immunoassay) is a Barcelona-based contract developer and manufacturer of custom antigens, antibodies, and bulk immunoassays for global IVD industry leaders, offering end-to-end assay lifecycle services from reagent development through regulatory registration and on-market support.
Ownership category
akta.pro rank

Biokit industry classification

Industry
Product category
In Vitro Diagnostics Manufacturing
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAB
Immunoassay Diagnostics (ELISA, chemiluminescence, serology)
SECONDARYHLAAAKAA
Biologic API/Drug Substance Manufacturing Services

Keywords

  • In vitro diagnostics
  • Immunoassay development
  • Antibody manufacturing
  • Antigen production
  • Biomaterial manufacturing

Where Biokit is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Biokit business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Custom Biomaterial Development and Manufacturing: Bespoke development and manufacturing of custom antibodies and antigens for IVD companies. Revenue is generated through project-based contracts with long-term customer relationships, typically involving development fees and ongoing supply agreements.
  2. Bulk Assay Supply: Large-scale production and supply of immunoassays in bulk format to global IVD industry players. Revenue generated through recurring bulk product orders.
  3. Branded Products for Blood Banks & Clinical Laboratories: Sale of branded diagnostic products to blood banks and clinical laboratories.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Biokit product offering

Product offering

Core offering

Biokit operates as Werfen Immunoassay, a Center of Excellence for Immunoassay and Biomaterials. The company provides custom development and bulk manufacturing of high-quality antibodies, antigens, and immunoassays for the global in vitro diagnostics (IVD) industry, and also offers branded finished diagnostic products for blood banks and clinical laboratories. Services span end-to-end assay lifecycle management including bespoke reagent design, optimization, large-scale production, clinical studies, worldwide regulatory registration, and on-market product support.

Product overview

Werfen Immunoassay operates as a Center of Excellence for Immunoassay and Biomaterials, offering a unified portfolio of products and services for the global IVD industry. The core product portfolio consists of biomaterials (antigens and antibodies) and bulk-format immunoassays, complemented by branded products for blood banks and clinical laboratories. These are supported by service offerings including customized immunoassay development and customized biomaterial development, enabling end-to-end assay lifecycle management from bespoke reagent development through large-scale production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biomaterials (Antigens and Antibodies) High-quality custom-developed antigens and antibodies specifically designed for immunoassays, serving as foundational biomaterials for IVD industry customers.
  • Immunoassays in Bulk Format Bulk assay supply of immunoassays for diagnostic manufacturers, providing large-scale production capabilities to meet diagnostic manufacturing needs.
  • Branded Products for Blood Banks and Clinical Laboratories Finished branded diagnostic products tailored for blood banking and clinical laboratory applications, including blood typing, compatibility testing, and transfusion safety reagents.
  • Customized Immunoassay Service Bespoke development of custom immunoassays tailored to specific diagnostic requirements, including assay design, optimization, and manufacturing for IVD company partners.
  • Customized Biomaterial Service Customized development and manufacturing of antibodies and antigens to meet specific customer requirements for diagnostic applications.

Quantifiable outcome

  • More than 60 long-term customer relationships in the IVD industry

Companies that use Biokit

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Biokit technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Biokit partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Biokit competitors and assessment

Company assessment

Direct peers

  • DiaSorin: Italy-headquartered IVD company focused on immunoassays and molecular diagnostics, with a similar European manufacturing heritage to Biokit. Overlaps directly in custom and bulk immunoassay reagent supply to clinical labs and IVD partners.
  • Hytest: Specialist provider of monoclonal antibodies and antigens specifically for IVD manufacturers, with a similar custom development and bulk-supply model to Biokit. A directly comparable niche competitor serving global IVD reagent demand.
  • GenScript: Global provider of custom antibody services, recombinant protein production, and IVD reagent supply with strong Asia-Pacific manufacturing scale. Directly comparable to Biokit in custom antibody/antigen development for IVD and life-science customers.
  • Surmodics: Provides IVD reagents, antibodies, and biomaterials to diagnostic manufacturers, including custom development services. Comparable to Biokit as a focused supplier of immunoassay components to global IVD companies.
  • Meridian Bioscience: US-based IVD company producing immunoassay reagents, antigens, and antibodies for diagnostic test manufacturers and clinical laboratories. Overlaps with Biokit in both IVD raw material supply and finished diagnostic test products.
  • Bio-Rad Laboratories: Major diagnostics and life-science company with a portfolio of IVD reagents, immunoassay kits, and quality controls that competes for the same clinical lab and IVD manufacturer customers as Biokit. Bio-Rad also offers custom reagent services, making it a close functional peer in immunoassay supply.
  • Fapon Biotech: China-based IVD raw-material supplier offering custom antibody and antigen development, bulk reagent manufacturing, and end-to-end IVD solutions. Closely comparable business model to Biokit, often positioned as a lower-cost alternative for global IVD manufacturers.

Broad incumbents

  • Merck (MilliporeSigma): Operates one of the largest antibody, antigen, and bioreagent catalogs globally, including custom antibody development services. Competes with Biokit for IVD manufacturers sourcing high-quality antibodies and antigens, though Merck's portfolio spans the full life-science research and bioprocessing markets.
  • Revvity (formerly PerkinElmer): Broad life-sciences and diagnostics company offering immunoassay reagents, custom antibody development, and IVD solutions across multiple modalities. Competitor in the IVD reagent supply space though not as specialized in IVD raw-material CDMO services as Biokit.
  • Thermo Fisher Scientific: Global life-sciences leader with a substantial antibodies and immunoassay reagents catalog serving IVD and research customers. Overlaps with Biokit in bulk antibody/antigen supply, though Thermo Fisher operates across a much broader life-sciences portfolio rather than specializing in custom IVD reagent CDMO services.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks5 records

Key highlights5 records

Customer concentration

Biokit financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biokit leadership team

Management profile

Number of profiles

Profiles1 record

Biokit funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biokit M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biokit

What does Biokit do?

Biokit operates as Werfen Immunoassay, a Center of Excellence for Immunoassay and Biomaterials. The company provides custom development and bulk manufacturing of high-quality antibodies, antigens, and immunoassays for the global in vitro diagnostics (IVD) industry, and also offers branded finished diagnostic products for blood banks and clinical laboratories. Services span end-to-end assay lifecycle management including bespoke reagent design, optimization, large-scale production, clinical studies, worldwide regulatory registration, and on-market product support.

Is Biokit a public or private company?

Biokit is a private company. It is classified as corporate owned and is currently operating.

When was Biokit founded?

Biokit was founded in 1973. It employs 11 to 50 people.

Where is Biokit based?

Biokit is headquartered in Barcelona, Spain, in the Europe region.

How does Biokit make money?

Three revenue lines are on record. Custom Biomaterial Development and Manufacturing is the primary driver. The others are bulk Assay Supply and branded Products for Blood Banks & Clinical Laboratories.

Who are Biokit's main competitors?

Direct peers on record are DiaSorin, Hytest, GenScript, Surmodics, Meridian Bioscience, Bio-Rad Laboratories and Fapon Biotech. Broad incumbents are Merck (MilliporeSigma), Revvity (formerly PerkinElmer) and Thermo Fisher Scientific.

Does Biokit have an API?

No public API is recorded for Biokit.

What industry is Biokit in?

Biokit's product category is In Vitro Diagnostics Manufacturing. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry), with a secondary code of HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals